Palvella Therapeutics, Inc. (PVLA)

CIK 1583648 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Palvella Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 20261440001967940-26-000050
Sep 4, 202640001104659-26-105494
Sep 2, 20261440001950047-26-008991
Aug 20, 202640001104659-26-099222
Aug 19, 20261440001967940-26-000044
Aug 14, 2026SCHEDULE 13G/A0001999371-26-018011
Aug 14, 2026SCHEDULE 13G/A0000921895-26-002180
Aug 10, 2026SCHEDULE 13G0001137774-26-000180
Aug 4, 202610-Q0001193125-26-331574
Aug 4, 20268-K0001193125-26-331556
Aug 4, 2026S-80001104659-26-090394
Aug 3, 2026SCHEDULE 13G0000053417-26-000050
Jul 29, 2026SCHEDULE 13G0002012383-26-002924
Jul 17, 202640001104659-26-084620
Jul 15, 20261440001967940-26-000039
Jul 14, 20268-K0001193125-26-303307
Jul 1, 202630001104659-26-079863
Jul 1, 202640001104659-26-079865
Jun 30, 20268-K0001104659-26-079087
Jun 22, 202640001104659-26-076460
Jun 17, 20261440001967940-26-000032
Jun 16, 202640001104659-26-074574
Jun 16, 20268-K0001104659-26-074338
Jun 12, 202640001104659-26-073437
Jun 12, 202640001104659-26-073432